Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Oskare Capital

Investor type Venture Capital
Founders Alexandre Ouimet-Storrs Bruce Linton Gaetano Insalaco Nicola Broughton

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 3
Rounds per year 3.00
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees Soon
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Bioinformatics
  • Biopharma
  • Wellness

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Oskare Capital:
Typical Co-investors
Oskare Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Oskare Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Audible New Jersey, Newark, United States
BC Select Fund -
Bilibili China, Shanghai
Brain Corp California, San Diego, United States
Bridger Healthcare Belle Fourche, South Dakota, United States
Chalhoub Group Dubai, United Arab Emirates
Chiba Dojo Japan, Tokyo
Chippewa Valley Angel Investors Network Eau Claire, United States, Wisconsin
Debeka -
Fashion 22 -
HP Ventures Group Chicago, Illinois, United States
Manhuadao China, Minhang, Shanghai
Metropolitan Venture Partners New York, New York, United States
Opportunities New Brunswick -
Optimist Capital -
Projector Ventures Russia, Sverdlovsk Oblast, Yekaterinburg
SeedersClub Bangkok, Krung Thep, Thailand
The Grosvenor Funds District of Columbia, United States, Washington
VANTEC Angel Network British Columbia, Canada, Vancouver
W. R. Berkley Innovation Labs New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Leva Clinic

Health Care
Medical
Wellness
$4M04 Nov 2022 London, England, United Kingdom

Octarine Bio

Bioinformatics
Biopharma
Biotechnology
Health Care
$2M20 Sep 2022 Copenhagen, Capital Region of Denmark, Denmark

Herbolea Biotech

Biotechnology
$5M26 Oct 2021 Firenze, Toscana, Italy

Octarine Bio

Bioinformatics
Biopharma
Biotechnology
Health Care
$1M11 Mar 2021 Copenhagen, Capital Region of Denmark, Denmark

Octarine Bio

Bioinformatics
Biopharma
Biotechnology
Health Care
$1M12 Nov 2020 Copenhagen, Capital Region of Denmark, Denmark

Octarine Bio

Bioinformatics
Biopharma
Biotechnology
Health Care
13 Jan 2020 Copenhagen, Capital Region of Denmark, Denmark

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oskare Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: